2BB score and signals
Allarity Therapeutics, Inc.’s current 2BB score is 14 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 7 | Very Weak |
| Quality | 20 | Weak |
| Risk | 26 | Low |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Employees | 7 |
| 52-week range | $0.77 – $1.84 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-29 | — | -0.2142 | — | $0.00 |
| 2026-11-14 | — | -0.2142 | — | $0.00 |
| 2026-08-15 | — | -0.255 | — | $0.00 |
| 2026-05-15 | -0.17 | -0.2244 | $25,000.00 | $0.00 |
Related companies
